License and Collaboration Agreement with ApolloBio Corp to Develop and Commercialize VGX-3100 in Greater China

Target Company Name:
Country:
Advisory:
Sector:
Partner:

Inovio Pharmaceuticals Inc.
USA
Advisor to the seller
Healthcare & Pharmaceuticals

Inovio will immediately receive $23 million in upfront payment; an additional $20 million in future regulatory milestone payments and double-digit tiered royalties on future sales.

License and Collaboration Agreement with ApolloBio Corp to Develop and Commercialize VGX-3100 in Greater China

Advisor to the seller

Relevant transactions

Transactions

Project Amygdala

Private Equity

Sale of mental health services provider for high-acuity individuals in the UK

Advisor to the seller :
Cooper Parry Corporate Finance

Private Investors

Sale of a minority stake of Genbio, a hemoderivatives producer, to Private Investors

Advisor to the seller :
RIóN

icotec, the world leader in the field of spinal tumor implants, has closed its USD 30m growth financing round led by MVM

Advisor

Alpha Source Group, a portfolio company of Baird Capital, acquired by Probo Medical.

Advisor to the seller :
Brown Gibbons Lang & Company